1:25pm ET
Health and Healthcare
Merck and Pfizer Earnings: What to Expect
Merck and Pfizer are set to report their most recent quarterly results before the opening bell tomorrow. Pfizer is one of the most shorted of all Dow stocks.
Companies
/Healthcare
Pfizer Inc
$27.72
▲ $0.07 (+0.25%) today
Markets closed · 5:01am ET
PFE Coverage
Page 316:50am ET
Investing
Apple, Chevron, Exxon, Pfizer and More Dow Earnings Coming This Week
Six of the 30 Dow Jones industrial average components are scheduled to report their latest quarterly reports this week.
9:59am ET
Health and Healthcare
Short Sellers Can’t Make Up Their Minds on Big Pharma
The October 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
7:05am ET
Investing
The 5 Most Shorted Dow Stocks
As of the most recently reported period, short sellers still favored Microsoft, Intel and Pfizer above all other Dow stocks.
6:45am ET
Health and Healthcare
How Biotech and Big Pharma Have Upside Heading Into Earnings
Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.
9:15am ET
Investing
Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, CSX, IBM, Netflix, Occidental Petroleum, Whiting Petroleum, Amgen, Gilead Sciences, Merck and Pfizer.
9:40am ET
Health and Healthcare
Big Pharma Sees Rising Tide in Short Interest
The September 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
7:05am ET
Investing
5 Most Shorted Dow Stocks
As of the most recently reported period, short sellers favored Microsoft, Intel and Pfizer above all other Dow stocks.
7:30am ET
Investing
5 Dow Jones Industrial Average 2019 Laggards Could Be Big Q4 Winners
The last thing investors want is a value trap loser that stays stagnant, but all these top companies have solid long-term prospects.
9:55am ET
Health and Healthcare
Good News for Teens Suffering Atopic Dermatitis
Pfizer has announced positive top-line results from a second Phase 3 pivotal study evaluating abrocitinib, in patients aged 12 and older with moderate to severe atopic dermatitis.
Chris Lange 9:20am ET
Health and Healthcare
Short Sellers Grow More Selective in Big Pharma
The September 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
6:35am ET
Investing
The 6 Most Shorted Dow Stocks
As of the most recently reported period, short sellers favored Pfizer, Intel and Microsoft above all other Dow stocks.
8:35am ET
Health and Healthcare
Short Sellers Can’t Make Up Their Minds on Big Pharma
The August 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks was mixed.
6:50am ET
Investing
The 5 Most Shorted Dow Stocks
As of the most recently reported period, short sellers favored Pfizer, Intel and Microsoft above all other Dow stocks.
8:35am ET
Health and Healthcare
Big Pharma Sees a Rising Tide in Short Interest
The August 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.